Digital health provider Numan has closed an extension of its Series B round at $60 million (£44.6 million), with an additional $27 million in growth capital from HSBC Innovation Banking. The round was led by Big Pi Ventures through its new Growth Fund strategy, joined by Endeavor Catalyst and existing investors White Star Capital and Novator Partners. Since 2018, Numan has raised a total of $130.7 million across six rounds, according to Crunchbase.
The new funding will support Numan’s expansion into female health, the enhancement of screening and preventative care programs, scaling of its infrastructure, broader marketing efforts, and further development of its AI-driven capabilities. The company’s growth trajectory has been strong, with revenues more than doubling to $90 million last year and a projected 150% growth this year.
Headquartered in London, Numan has treated over 650,000 patients across obesity management, men’s health, and diagnostics, while maintaining a net promoter score of 68—well above the healthcare industry average and within the top quartile of benchmarks. “We are now perfectly positioned to expand our reach, deepen our clinical capabilities, and accelerate innovation to help our patients live happier, healthier, longer lives,” said CEO Sokratis Papafloratos. Big Pi Ventures partner Nick Kalliagkopoulos praised the company’s momentum, citing its “exceptional growth and clear vision to tackle some of healthcare’s most pressing challenges, from obesity to hormonal health.”
Click here to read the original news story.